Skip to main content

Table 1 Characteristics of study participantsa, b

From: Effect of novel technology-enabled multidimensional physical activity feedback in primary care patients at risk of chronic disease – the MIPACT study: a randomised controlled trial

Variable

Total (n = 204)

Control (n = 70)

Intervention (n = 134)

Age (years)

64 (6)

63 (6)

64 (6)

Male sex

131 (64)

45 (64)

86 (64)

Ethnicity: White British

180 (88)

63 (90)

117 (87)

Marital Status: Married

150 (74)

54 (77)

96 (72)

Employment status

 In full or part-time employment

85 (42)

31 (44)

54 (40)

 Retired

116 (57)

38 (54)

78 (58)

Area deprivation (IMD score)

7.6 (2.3)

7.7 (2.4)

7.6 (2.3)

Education levels

 Up to age 16 or less

63 (31)

18 (26)

45 (34)

 Up to age 18

60 (29)

26 (37)

34 (25)

 Undergraduate / higher degree

81 (40)

26 (37)

55 (41)

Current smoker

20 (10)

10 (14)

10 (7)

Body mass (kg)

85.2 (14.3)

86.6 (14.1)

84.5 (14.4)

Body mass index (kg/m2)

29.1 (4.4)

29.4 (4.3)

28.9 (4.4)

DEXA

 Total body fat (%)

33.4 (8.1)

33.0 (8.5)

33.5 (7.9)

 Visceral body fat (cm2)

188 (60)

195 (66)

184 (57)

 Fat mass index (kg/m2)

9.7 (3.5)

9.7 (3.6)

9.7 (3.4)

Waist circumference (cm)

100.3 (10.6)

101.2 (10.6)

99.8 (10.5)

Blood pressure (mm Hg)

 Systolic

132 (16)

132 (17)

132 (16)

 Diastolic

84 (9)

83 (10)

84 (9)

Fasting glucose (mmol/L)

5.1 (0.5)

5.1 (0.5)

5.1 (0.4)

Fasting insulin (mU/L) median (IQR)

54.8 (41.1, 82.2)

58.9 (37.5, 84.1)

51.4 (42.4, 80.4)

HOMA-IR median (IQR)

1.8 (1.3, 2.7)

1.9 (1.2, 2.8))

1.7 (1.3, 2.6)

Cholesterol (mmol/L)

 Total cholesterol

5.8 (1.0)

5.7 (0.9)

5.9 (1.1)

 Low-density lipoprotein cholesterol

3.6 (0.9)

3.5 (0.9)

3.7 (1.0)

 High-density lipoprotein cholesterol

1.6 (0.4)

1.5 (0.4)

1.6 (0.5)

Triglycerides (mmol/L)

1.4 (0.6)

1.4 (0.7)

1.4 (0.6)

QRISK2: 10-year risk (%)

14.4 (6.3)

13.8 (6.2)

14.8 (6.4)

QDiabetes: 10-year risk (%)

13.5 (9.4)

12.9 (6.9)

13.9 (10.5)

Physical Activity

 Sedentary time (min/day)

662 (111)

651 (117)

668 (107)

 MVPA (min/day)

149 (57)

157 (60)

146 (56)

 MVPA10 (min/day)

96 (47)

103 (52)

92 (44)

 Vigorous10 (min/day) median (IQR)

3 (0, 9)

3 (0, 11)

3 (0, 8)

 PAL

1.68 (0.16)

1.70 (0.16)

1.67 (0.16)

EQ 5-D VAS

72 (16)

73 (16)

71 (15)

  1. Abbreviations: IMD Index of multiple deprivation, DEXA Dual-energy X-ray absorptiometry, HOMA-IR Homeostatic model assessment – Insulin resistance, PAL Physical activity level, EQ. 5-D VAS Euroqol 5-D visual analogue scale (health-related quality of life)
  2. a Data are expressed as mean (SD) for continuous data, or N (%) for categorical data. Highly skewed continuous data are presented as median (interquartile range; IQR)
  3. bN = 186 for DEXA; N = 204 for all other variables